Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.
作者信息
Rejeski Kai, Burchert Andreas, Iacoboni Gloria, Sesques Pierre, Fransecky Lars, Bücklein Veit, Trenker Corinna, Hernani Rafael, Naumann Ralph, Schäfer Jonas, Blumenberg Viktoria, Schmidt Christian, Sohlbach Kristina, von Bergwelt-Baildon Michael, Bachy Emmanuel, Barba Pere, Subklewe Marion
机构信息
Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany.
Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
出版信息
Blood Adv. 2022 Aug 23;6(16):4719-4725. doi: 10.1182/bloodadvances.2022007776.
Abstract
摘要
Zotero 插件